Gastric Balloon

We use our own and third party cookies to improve the user experience through your browsing.Cookies Policy

BARIATRIC SURGERY - OBESITY TREATMENT

Mechanism of action

Temporary restriction of the patient's stomach volume by the placement of a gastric balloon. This contributes to modifying eating habits and loosing weight. It produces a decrease in food intake and early satiety in the patient. 

Indications

It is indicated for patients with BMI between 28 and 40.

Procedure Duration

It takes 30 minutes to place the gastric balloon and 30 minutes to remove it.

Hospital Stay

1 Hour. Both the ingestible and ingestible-digestible do not require endoscopy nor anesthesia, only x-ray monitoring.

Return to normal activity
2-3 days

Monitoring
Removal after 3,6 or 12 months or spontaneous disposal after 4 months depending on balloon type. Monitoring after 12-18 months conducted by Doctor, Psychologist, Nutritionist and Personal Trainer. 

Pros
Simple and Secure

Cons
TEMPORARY technique for weight loss. High weight regain incidence, specially in patients with BMI > 33-35.

Low-Risk option
Low risk in the gastric balloon's placement.

Grade of recommendation with available scientific evidence 
High recommendation. Highest in 6 months balloon (as approved by FDA)

Results
60% Loss of excess weight in BMI 30-35. Weight regain after 2 years in 50% of patients.

Videos


Testimonial
Primer balón ajustable de la Comunidad por IntraObes

IntraObes scientific publications and relevant facts about this technique

  • Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg. 2008 Dec;18(12):1611-7. doi: 10.1007/s11695-008-9593-9. Epub 2008 Jun 21.
  • Breton, E. Cancer, C. Mellado, V. Abilés, J. Avilés, M. A. Escarti, R. Ginés, V. Álvarez, N. Paez, C. Velasco, L. Pavón, M. Miras, M. Martínez Olmo, J. M. Culebras, R.-A. Mazure, I. Balón Intragástrico en el Tratamiento de la Obesidad. Grupo de trabajo OBESMINVA de la SENPE. Nutr. Hosp. 24 (2) 2009.
  • Consentimiento informado en el balón intragástrico avalado por SENPE, SEEDO, SEN y SECO; aspectos médico-legales. V. Abilés, M. A. Martínez Olmos, M. A. Escartí, I. Bretón, E. Cáncer, N. Pelaez, V. Álvarez, J. M. Culebras, R. A. Mazure; Grupo de Trabajo OBESMINVA de la SENPE . Nutr. Hosp. 27 (2) 2012.